Sign up to view this video Join Now Commercialization, • 9/19/25 What Matters to Payers: Conversations You Should Start During Phase 2 Previous Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Next Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories You Might Also Like Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies
Sign up to view this video Join Now Commercialization, • 9/19/25 What Matters to Payers: Conversations You Should Start During Phase 2 Previous Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Next Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories You Might Also Like Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies
